Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tom Luedde

Showing results (11-20 of 459) with videos related to

Pageof 46
Sort By:
Nature Reviews. Gastroenterology & Hepatology|September 26, 2018
Apoptosis and necroptosis in the liver: a matter of life and deathRobert F Schwabe, Tom Luedde
Deutsches Arzteblatt International|April 12, 2022
In ReplySven H Loosen, Tom Luedde
Hepatology (Baltimore, Md.)|July 28, 2011
MicroRNA-199a/b-3p: a new star in the liver microcosmosChristoph Roderburg, Christian Trautwein, Tom Luedde
Cellular and Molecular Gastroenterology and Hepatology|February 18, 2017
Necroptosis in Nonalcoholic SteatohepatitisJérémie Gautheron, Mihael Vucur, Tom Luedde
Clinical Reviews in Allergy & Immunology|July 5, 2008
Inflammatory pathways in liver homeostasis and liver injuryFrank Tacke, Tom Luedde, Christian Trautwein
Journal of Hepatology|September 14, 2021
Reply to: "Multiple investigations for a very common disorder: Finding the right balance in NAFLD"Tom Luedde, Ulrich Baumann, Verena Keitel
Journal of Gastroenterology and Hepatology|September 9, 2006
Evaluation of the role of nuclear factor-kappaB signaling in liver injury using genetic animal modelsTom Luedde, Naiara Beraza, Christian Trautwein
Viszeralmedizin|October 16, 2015
Biliary Mucosal Barrier and MicrobiomeJulien Verdier, Tom Luedde, Gernot Sellge
Digestive Diseases (Basel, Switzerland)|October 31, 2012
TNF-dependent signaling pathways in liver cancer: promising targets for therapeutic strategies?Christoph Roderburg, Jeremie Gautheron, Tom Luedde
Journal of Hepatology|September 6, 2017
Reply to: "Is osteopontin a promising prognostic biomarker for cholangiocarcinoma?"Sven H Loosen, Christoph Roderburg, Tom Luedde
Pageof 46

Showing results (11-20 of 459) with videos related to

Sort By:
Pageof 46
Nature Reviews. Gastroenterology & Hepatology|September 26, 2018
Apoptosis and necroptosis in the liver: a matter of life and deathRobert F Schwabe, Tom Luedde
Deutsches Arzteblatt International|April 12, 2022
In ReplySven H Loosen, Tom Luedde
Hepatology (Baltimore, Md.)|July 28, 2011
MicroRNA-199a/b-3p: a new star in the liver microcosmosChristoph Roderburg, Christian Trautwein, Tom Luedde
Cellular and Molecular Gastroenterology and Hepatology|February 18, 2017
Necroptosis in Nonalcoholic SteatohepatitisJérémie Gautheron, Mihael Vucur, Tom Luedde
Clinical Reviews in Allergy & Immunology|July 5, 2008
Inflammatory pathways in liver homeostasis and liver injuryFrank Tacke, Tom Luedde, Christian Trautwein
Journal of Hepatology|September 14, 2021
Reply to: "Multiple investigations for a very common disorder: Finding the right balance in NAFLD"Tom Luedde, Ulrich Baumann, Verena Keitel
Journal of Gastroenterology and Hepatology|September 9, 2006
Evaluation of the role of nuclear factor-kappaB signaling in liver injury using genetic animal modelsTom Luedde, Naiara Beraza, Christian Trautwein
Viszeralmedizin|October 16, 2015
Biliary Mucosal Barrier and MicrobiomeJulien Verdier, Tom Luedde, Gernot Sellge
Digestive Diseases (Basel, Switzerland)|October 31, 2012
TNF-dependent signaling pathways in liver cancer: promising targets for therapeutic strategies?Christoph Roderburg, Jeremie Gautheron, Tom Luedde
Journal of Hepatology|September 6, 2017
Reply to: "Is osteopontin a promising prognostic biomarker for cholangiocarcinoma?"Sven H Loosen, Christoph Roderburg, Tom Luedde
Pageof 46